INmune Bio (NASDAQ: INMB) Phase 2 Alzheimer’s trial results failed to meet the primary endpoint INmune Bio Inc. (NASDAQ: INMB) stock fell 60% in pre-market trading Monday after the company reported mixed results from its Phase 2 MINDFuL trial of XPro in early...
DNOW Inc. (NYSE: DNOW) to acquire MRC Global in $1.5 billion all-stock deal DNOW announced an all-stock acquisition of MRC Global valued at approximately $1.5 billion, expected to generate $70 million in annual cost synergies and expand their global footprint, while...
The FDA has updated the labels for Pfizer and Moderna COVID-19 vaccines The FDA has updated the labels for Pfizer and Moderna COVID-19 vaccines to highlight the risk of myocarditis and pericarditis, particularly in young males, which may affect public perception and...
ZenaTech (Nasdaq: ZENA) Signs Offer to Acquire North Carolina Land Surveying Company ZenaTech, Inc. (Nasdaq: ZENA) announces it has signed an offer to acquire a well-established North Carolina-based land surveying company with a strong government customer base. The...
NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Announce Agreement to Acquire Interest in Cohen and Associates HOPE Therapeutics™, Inc. (“HOPE”), a multi-site clinical care delivery organization and wholly owned subsidiary of NRx Pharmaceuticals, Inc. (NRXP),...
Rubrik (NYSE: RBRK) to Acquire Predibase Rubrik, Inc. (NYSE: RBRK) announced it has entered into an agreement to acquire Predibase to accelerate agentic AI adoption from pilot to production at scale. Together, Predibase and Rubrik will deliver radical simplicity in...
